Evidence map›Paper›PMID 36648136›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2023

Plasma metabolic profiling implicates dysregulated lipid metabolism and glycolytic shift in hyperinflammatory ARDS.

Narges Alipanah-Lechner, Lucile Neyton, Eran Mick, Andrew Willmore, Aleksandra Leligdowicz, Kévin Contrepois, Alejandra Jauregui, Hanjing Zhuo, Carolyn Hendrickson, Antonio Gomez and 6 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. PCSK9 in critical illness - It's not all about lipids.Annals of clinical biochemistry · 2026
    Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Bioenergetics and metabolism of the pulmonary endothelium. Scientific session I: ReSPIRE 2025.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. The Plasma Lipidomic Landscape in Patients with Sepsis due to Community-acquired Pneumonia.American journal of respiratory and critical care medicine · 2024
    Article
  18. "Now We Got Bad Blood": Beyond Phenotype Labels in an "Era" of Meta-omics in Critical Illness.American journal of respiratory and critical care medicine · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Narges Alipanah-LechnerDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, United States.ORCID 0000-0002-8381-5701
Lucile NeytonDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, United States.ORCID 0000-0003-1273-2228
Eran MickDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, United States.ORCID 0000-0002-7299-808X
Andrew WillmoreDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, United States.
Aleksandra LeligdowiczCardiovascular Research Institute, University of California, San Francisco, California, United States.ORCID 0000-0001-6055-4644
Kévin ContrepoisDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States.
Alejandra JaureguiDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, United States.
Hanjing ZhuoCardiovascular Research Institute, University of California, San Francisco, California, United States.
Carolyn HendricksonDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, United States.
Antonio GomezDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, United States.
Pratik SinhaDivision of Clinical and Translational Research, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States.
Kirsten N KangelarisDivision of Hospital Medicine, Department of Medicine, University of California, San Francisco, California, United States.
Kathleen D LiuCardiovascular Research Institute, University of California, San Francisco, California, United States.
Michael A MatthayDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, United States.ORCID 0000-0003-3039-8155
Angela J RogersDivision of Pulmonary and Critical Care, Department of Medicine, Stanford University, Stanford, California, United States.ORCID 0000-0001-6969-6200
Carolyn S CalfeeDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, California, United States.ORCID 0000-0001-9208-6865
University of California, San Francisco · USSan Francisco General Hospital · USStanford University · USWashington University in St. Louis · US

Funding

MUTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007185 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI David J Erle, LAURENCE HUANG · 1985 to 2026
$24.6M
Precision Medicine in the Acute Respiratory Distress SyndromeR35HL140026 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CALFEE, CAROLYN · 2018 to 2024
$6.8M
Molecular characterization of pulmonary edema: a window to an injured lungR01HL152083 · NHLBI · STANFORD UNIVERSITY · PI ROGERS, ANGELA J · 2020 to 2024
$2.9M
Precision Medicine in Sepsis with Critical IllnessR35GM142992 · NIGMS · WASHINGTON UNIVERSITY · PI Pratik Sinha · 2021 to 2026
$2.4M
NHLBI NIH HHS R01 HL152083NHLBI NIH HHS R35 HL140026NHLBI NIH HHS T32 HL007185NIGMS NIH HHS R35 GM142992
6 · The paper itself

Abstract

Using latent class analysis (LCA) of clinical and protein biomarkers, researchers have identified two phenotypes of the acute respiratory distress syndrome (ARDS) with divergent clinical trajectories and treatment responses. We investigated whether plasma metabolites differed among patients with LCA-derived hyperinflammatory and hypoinflammatory ARDS, and we tested the prognostic utility of adding metabolic clusters to LCA phenotypes. We analyzed data from 93 patients with ARDS and sepsis enrolled in a multicenter prospective cohort of critically ill patients, comparing 970 metabolites between the two LCA-derived phenotypes. In all, 188 metabolites were differentially abundant between the two LCA-derived phenotypes. After adjusting for age, sex, confounding medications, and comorbid liver and kidney disease, 82 metabolites remained significantly different. Patients with hyperinflammatory ARDS had reduced circulating lipids but high levels of pyruvate, lactate, and malate. Metabolic cluster and LCA-derived phenotypes were each significantly and independently associated with survival. Patients with hyperinflammatory ARDS may be experiencing a glycolytic shift leading to dysregulated lipid metabolism. Metabolic profiling offers prognostic information beyond what is captured by LCA phenotypes alone. Deeper biological profiling may identify key differences in pathogenesis among patients with ARDS and may lead to novel targeted therapies.

Indexed as

Lipid MetabolismRespiratory Distress SyndromeBiomarkersHumansPhenotypeProspective StudiesBiomarkersARDSlatent class analysismetabolomicsphenotypingprecision medicine

Identifiers

PMID36648136
PMCPMC9988532
OpenAlexW4316928210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.